secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2026-07-31T11:23:30+00:00
Accession:  0001193125-26-326785
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inovio prices $20M public offering of common stock and warrants
---------------------------------------------------------------

- Offering of 21,052,632 shares and warrants to purchase up to 42,105,264 shares at $1.10 exercise price.
- Combined price $0.95 per share and warrant; gross proceeds $20M, net proceeds ~$18.3M.
- Underwriter Piper Sandler; option exercised for additional warrants to buy 6,315,788 shares.
- Closing expected on or about July 31, 2026, subject to customary conditions.
- Proceeds intended for general corporate purposes; no specific use disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312526326785/0001193125-26-326785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312526326785/d253972d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-326785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer